Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 28272710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coding-noncoding gene expression in intrahepatic cholangiocarcinoma.

  2016cited by this paper
• Expression profile of microRNA‐200 family in cholangiocarcinoma arising from choledochal cyst

  2016cited by this paper
• Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.

  2016cited by this paper
• The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma

  2016cited by this paper
• Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.

  2015cited by this paper
• Role of surgery in the treatment of intrahepatic cholangiocarcinoma.

  2015cited by this paper
• MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.

  2015cited by this paper
• Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy.

  2015cited by this paper
• Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma

  2015cited by this paper
• MicroRNAs in the Biology and Diagnosis of Cholangiocarcinoma

  2015cited by this paper
• Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type

  2015cited by this paper
• Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.

  2015cited by this paper
• Needle-based confocal laser endomicroscopy

  2015cited by this paper
• Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate

  2015cited by this paper
• Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics.

  2015cited by this paper
• Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

  2015cited by this paper
• Prognostic significance of microRNA-203 in cholangiocarcinoma.

  2015cited by this paper
• What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma?

  2014cited by this paper
• Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.

  2014cited by this paper
• New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.

  2014cited by this paper
• Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

  2014cited by this paper
• Efficacy of SpyGlass(TM)-directed biopsy compared to brush cytology in obtaining adequate tissue for diagnosis in patients with biliary strictures.

  2014cited by this paper
• Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.

  2014cited by this paper
• Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.

  2014cited by this paper
• Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.

  2014cited by this paper
• Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

  2013cited by this paper
• Clinicopathological features of early distal cholangiocarcinoma.

  2013cited by this paper
• Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

  2013cited by this paper
• Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers

  2013cited by this paper
• Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

  2013cited by this paper
• Activated hepatic stellate cells mediate the differentiation of macrophages

  2013cited by this paper
• Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

  2013cited by this paper
• Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

  2012cited by this paper
• Exome sequencing of liver fluke–associated cholangiocarcinoma

  2012cited by this paper
• Cholangiocarcinomas can originate from hepatocytes in mice.

  2012cited by this paper
• Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats

  2012cited by this paper
• Genetic profiling of intrahepatic cholangiocarcinoma

  2012cited by this paper
• Down‐regulation of miR‐214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist

  2012cited by this paper
• Mutations in Isocitrate Dehydrogenase 1 and 2 Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas

  2012cited by this paper
• MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression.

  2012cited by this paper
• MicroRNAs in liver disease.

  2012cited by this paper
• Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

  2012cited by this paper
• Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway

  2012cited by this paper
• miR‐25 targets TNF‐related apoptosis inducing ligand (TRAIL) death receptor‐4 and promotes apoptosis resistance in cholangiocarcinoma

  2012cited by this paper
• MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.

  2012cited by this paper
• The Usefulness of SpyGlass™ Choledochoscopy in the Diagnosis and Treatment of Biliary Disorders

  2012cited by this paper
• Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.

  2012cited by this paper
• Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.

  2012cited by this paper
• The Hippo signaling pathway and stem cell biology.

  2012cited by this paper
• Genetic Factors in the Pathogenesis of Cholangiocarcinoma

  2011cited by this paper
• Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience.

  2011cited by this paper
• Confocal Endomicroscopic Examination of Malignant Biliary Strictures and Histologic Correlation With Lymphatics

  2011cited by this paper
• Mst 1 and Mst 2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap 1 Oncogene

  2011cited by this paper
• The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

  2010cited by this paper
• Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

  2010cited by this paper
• The clinical potential of microRNAs

  2010cited by this paper
• Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development

  2010cited by this paper
• WHO Classification of Tumours of the Digestive System

  2010cited by this paper
• Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

  2009cited by this paper
• Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

  2009cited by this paper
• Optical coherence tomography for bile and pancreatic duct imaging.

  2009cited by this paper
• MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.

  2009cited by this paper
• EFFECTIVENESS OF PERORAL CHOLANGIOSCOPY AND NARROW BAND IMAGING FOR ENDOSCOPICALLY DIAGNOSING THE BILE DUCT CANCER

  2009cited by this paper
• Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.

  2008cited by this paper
• Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

  2008cited by this paper
• The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes*

  2007cited by this paper
• Cholangiocarcinoma.

  2005cited by this paper
• The epidemiology of cholangiocarcinoma.

  2004cited by this paper
• Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

  2004cited by this paper
• Transendoscopic ultrasound mini-probes, are they necessary?

  2003cited by this paper

• Cholangiocarcinogenesis and targeted therapy for cholangiocarcinoma

  2021cites this paper
• Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis

  2020cites this paper
• Personalised approach in combined treatment of cholangiocarcinoma: a case report of healing from cholangiocellular carcinoma at stage IV.

  2019influential citation
• Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI

  2019cites this paper
• miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion

  2019cites this paper
• Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis

  2018influential citation
• Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma

  2018cites this paper